Client News
MagForce AG Publishes Financial Results for the First Half of 2020 and Operative Highlights
InflaRx Reports Q3 2020 Financial & Operating Results
Verona Pharma plc: Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price
Verona Pharma plc: Verona Pharma Provides Update on AIM Delisting
XPHYTO Therapeutics announces RT-PCR test for point-of-care COVID-19 detection
Eternygen Announces the First Closing of its Series A2 Funding Round
Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020
Verona Pharma plc: Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update
